Skip to content

Aurinia Pharmaceuticals Inc.

AUPH Nasdaq SEC CIK 1600620

Follow Aurinia Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under Aurinia Pharmaceuticals

Markets

Thread · 3 stories

Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?

Markets 27 d ago also on TEVA

Aurinia Pharmaceuticals Doubles Down On Its Pipeline

Markets 43 d ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress

Markets 49 d ago

Next results

NOV5

FY 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: EDMONTON
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 3 stories clustered from the RSS aggregator